![]() |
![]() |
Important investment information and business conditions such as general meetings and settlements.
Each year 20-30% of sales is re-invested in research securing a diverse range of core technologies to advance as a global research center for DDS technologies and biodegradable material medical devices.
Samyang Biopharmaceuticals Corp. has acquired a wide range of innovative technologies and will continue to actively pursue acquisition of technologies in promising fields with high growth potential.
Samyang Biopharmaceuticals Corp. focuses in developing new medical products and trends in advanced biodegradable base materials that will revolutionize medicine in the future.
Samyang Biopharmaceuticals Corp. pursues innovation through collaborative research and development with academic institutions and industry.